MAP30 protein from Momordica charantia is therapeutic and...

  • Main
  • 2020 / 8
  • MAP30 protein from Momordica charantia is therapeutic and...
Pharmacological Research 2020 / 8

MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis

Chan, David W, Yung, Mingo MH, Chan, Yau-Sang, Xuan, Yang, Yang, Huijuan, Xu, Dakang, Zhan, Jin-Biao, Chan, Karen KL, Ng, Tzi-Bun, Ngan, Hextan YS
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Pharmacological Research
DOI:
10.1016/j.phrs.2020.105157
Date:
August, 2020
File:
PDF, 3.49 MB
2020
Conversion to is in progress
Conversion to is failed